Cryo-EM structures of hIAPP fibrils seeded by patient-extracted fibrils reveal new polymorphs and conserved fibril cores

Amyloidosis of human islet amyloid polypeptide (hIAPP) is a pathological hallmark of type II diabetes (T2D), an epidemic afflicting nearly 10% of the world’s population. To visualize disease-relevant hIAPP fibrils, we extracted amyloid fibrils from islet cells of a T2D donor and amplified their quan...

Full description

Saved in:
Bibliographic Details
Published inNature structural & molecular biology Vol. 28; no. 9; pp. 724 - 730
Main Authors Cao, Qin, Boyer, David R., Sawaya, Michael R., Abskharon, Romany, Saelices, Lorena, Nguyen, Binh A., Lu, Jiahui, Murray, Kevin A., Kandeel, Fouad, Eisenberg, David S.
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.09.2021
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Amyloidosis of human islet amyloid polypeptide (hIAPP) is a pathological hallmark of type II diabetes (T2D), an epidemic afflicting nearly 10% of the world’s population. To visualize disease-relevant hIAPP fibrils, we extracted amyloid fibrils from islet cells of a T2D donor and amplified their quantity by seeding synthetic hIAPP. Cryo-EM studies revealed four fibril polymorphic atomic structures. Their resemblance to four unseeded hIAPP fibrils varies from nearly identical (TW3) to non-existent (TW2). The diverse repertoire of hIAPP polymorphs appears to arise from three distinct protofilament cores entwined in different combinations. The structural distinctiveness of TW1, TW2 and TW4 suggests they may be faithful replications of the pathogenic seeds. If so, the structures determined here provide the most direct view yet of hIAPP amyloid fibrils formed during T2D. Human islet amyloid polypeptide (hIAPP) is a protein commonly forming aggregates in islet cells of those afflicted by type II diabetes. New structures of fibrils seeded with patient-derived material reveal a diverse repertoire of structures, some of which may resemble those appearing in vivo.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Q.C. designed experiments and performed data analysis. F.K. prepared islet cells from donors. Q.C. and L.S. performed Congo red staining of islet cells. Q.C., L.S., and B.A.N. performed fibril extraction from islet cells. Q.C. and R.A. performed immunoprecipitation in fibril extraction. R.A. and J.L. performed western blot and MTT assays. K.A.M. helped in western blot. Q.C. prepared hIAPP fibrils and cryo-EM grids. Q.C. and D.R.B. collected cryo-EM data. Q.C. performed cryo-EM data processing and model building, J.L. assisted in particle picking. Q.C. and M.R.S. performed solvation energy calculation. All authors analyzed the results and wrote the manuscript. D.S.E. supervised and guided the project.
Author contributions
ISSN:1545-9993
1545-9985
DOI:10.1038/s41594-021-00646-x